{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2014"],"condition":["Colorectal Neoplasms","Patients That Have Been Diagnosed With Colorectal Cancer","Patients Eligible for Tumor Biopsy"],"disease":["Colorectal Neoplasms","Patients Eligible For Tumor Biopsy","Patients That Have Been Diagnosed With Colorectal Cancer"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2140050"],"location":["Israel"],"study_start_month":["1"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"NovellusDx Tissue Collection Protocol","description":"NovellusDx is developing a diagnostic platform for the personalized cancer therapy based on patient derived tumor tissue. The assay is able to sense activating mutations by monitoring their effect on a chip-based device.","dates":{"creation":"2014-01-15"},"accession":"2140050","cross_references":{"ClinicalTrials___gov":["NCT01791322"]}}